IP Library Granted Patent US 8,747,919
Granted Patent B2
US 8,747,919 · App. 13/988,376 · Granted Jun 10, 2014

Pharmaceutical composition and method of preparing same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,747,919
App. No.
13/988,376
Granted
Jun 10, 2014
Kind
B2
Abstract

An object of the present invention is to provide a pharmaceutical composition comprising an enzyme-treated human serum which is useful for treatment and prevention of diseases such as a cancer and an infectious disease, and a method of preparing the same. The present invention relates to a method of preparing a pharmaceutical composition comprising an enzyme-treated human serum, comprising a step of bringing the human serum into contact with β-galactosidase and, to a pharmaceutical composition comprising an enzyme-treated human serum obtained by the preparation method.

Claims (8)

1. A method of treating a human suffering from cancer, consisting essentially of:

administering a therapeutically effective amount of a pharmaceutical composition consisting essentially of a beta-galactosidase and sialidase treated human serum to the human suffering from cancer,

said composition being prepared by bringing a human serum from blood of a healthy human into contact with beta-galactosidase and sialidase to yield the pharmaceutical composition.

2. The method of claim 1 , wherein the pharmaceutical composition consists essentially of proteins in an amount of 0.1 mg/kg to 0.4 mg/kg per dose.

3. A method of treating a human suffering from HIV or AIDS, consisting essentially of:

administering a therapeutically effective amount of a pharmaceutical composition consisting essentially of a beta-galactosidase and sialidase treated human serum to the human suffering from HIV or AIDS,

said composition being prepared by bringing a human serum from blood of a healthy human into contact with beta-galactosidase and sialidase to yield the pharmaceutical composition.

4. The method of claim 3 , wherein the pharmaceutical composition consists essentially of proteins in an amount of 0.1 mg/kg to 0.4 mg/kg per dose.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2017
From: TOKUSHIMA UNIVERSITY
To: SAISEI MIRAI CLINIC
Reel/Frame 041226/0455 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE FIRST ASSIGNEE PREVIOUSLY RECORDED ON REEL 030457 FRAME 0080. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 28, 2016
From: UTO, YOSHIHIRO; HORI, HITOSHI; INUI, TOSHIO; KUBO, KENTARO
To: SAISEI MIRAI CLINIC; TOKUSHIMA UNIVERSITY
Reel/Frame 039504/0038 →
CHANGE OF ENGLISH NAME Recorded Jan 28, 2016
From: THE UNIVERSITY OF TOKUSHIMA
To: TOKUSHIMA UNIVERSITY
Reel/Frame 037630/0710 →
CHANGE OF NAME Recorded Aug 5, 2015
From: THE UNIVERSITY OF TOKUSHIMA
To: TOKUSHIMA UNIVERSITY
Reel/Frame 036281/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2013
From: UTO, YOSHIHIRO; HORI, HITOSHI; INUI, TOSHIO; KUBO, KENTARO
To: SAISEI MIRAI CLINIC; THE UNIVERSITY OF TOKUSHIMA
Reel/Frame 030457/0080 →